Wall Street analysts expect that Intellia Therapeutics Inc (NASDAQ:NTLA) will report sales of $7.70 million for the current fiscal quarter, according to Zacks Investment Research. Five analysts have provided estimates for Intellia Therapeutics’ earnings. The highest sales estimate is $10.63 million and the lowest is $5.00 million. Intellia Therapeutics posted sales of $7.68 million during […]
